Blairsoldman, I agree with you but in my years in the industry I have seen companies put out some pretty shoddy products and make exorbitant claims that were untrue and that resulted in the death of patients. I have known executives that had criminal charges filed against them for that type of behavior so the FDA clamped down on the industry and went the other way making it harder to get products to market resulting in the deaths of patients who couldn’t get legitimate treatments but the FDA can’t be accused of negligence. It’s far easier to get clinical studies completed and therapies and products accepted for use outside of the US so many companies go internationally for their clinical studies. It seems to be easier to get domestic FDA approval for products already accepted internationally and the clinical study data can also be used for US approval.
News 
Market Data 
Discover 
